These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 6373462

  • 1. Preceding hyperinsulinemia prevents demonstration of insulin effect on fat-induced gastric inhibitory polypeptide (GIP).
    Stöckmann F, Ebert R, Creutzfeldt W.
    Diabetes; 1984 Jun; 33(6):580-5. PubMed ID: 6373462
    [Abstract] [Full Text] [Related]

  • 2. Interaction of fat-stimulated gastric inhibitory polypeptide on pancreatic alpha and beta cell function.
    Verdonk CA, Rizza RA, Nelson RL, Go VL, Gerich JE, Service FJ.
    J Clin Invest; 1980 May; 65(5):1119-25. PubMed ID: 6988457
    [Abstract] [Full Text] [Related]

  • 3. Response of circulating somatostatin, insulin, gastrin and GIP, to intraduodenal infusion of nutrients in normal man.
    Lucey MR, Fairclough PD, Wass JA, Kwasowski P, Medbak S, Webb J, Rees LH.
    Clin Endocrinol (Oxf); 1984 Sep; 21(3):209-17. PubMed ID: 6148162
    [Abstract] [Full Text] [Related]

  • 4. Effect of pretreatment with a high fat diet on the gastric inhibitory polypeptide and insulin responses to oral triolein and glucose in rats.
    Hampton SM, Kwasowski P, Tan K, Morgan LM, Marks V.
    Diabetologia; 1983 Apr; 24(4):278-81. PubMed ID: 6345248
    [Abstract] [Full Text] [Related]

  • 5. The effect of atropine on plasma gastric inhibitory polypeptide (GIP), serum insulin, and blood glucose after intraduodenal infusion of fat.
    Jorde R, Burhol PG, Waldum HL.
    Scand J Gastroenterol; 1981 Apr; 16(3):331-6. PubMed ID: 16435472
    [Abstract] [Full Text] [Related]

  • 6. Modifications of gastric inhibitory polypeptide (GIP) secretion in man by a high-fat diet.
    Morgan LM, Hampton SM, Tredger JA, Cramb R, Marks V.
    Br J Nutr; 1988 May; 59(3):373-80. PubMed ID: 3293660
    [Abstract] [Full Text] [Related]

  • 7. Effect of graded intraduodenal glucose infusions on the release and physiological action of gastric inhibitory polypeptide.
    McCullough AJ, Miller LJ, Service FJ, Go VL.
    J Clin Endocrinol Metab; 1983 Feb; 56(2):234-41. PubMed ID: 6337173
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of gastric secretion by fat and hypertonic glucose in the dog: role of gastric inhibitory peptide.
    Creutzfeldt W, Ebert R, Finke U, Konturek SJ, Kwiecień N, Radecki T.
    J Physiol; 1983 Jan; 334():91-101. PubMed ID: 6864570
    [Abstract] [Full Text] [Related]

  • 9. Different response of gastric inhibitory polypeptide to glucose and fat from duodenum and jejunum.
    Schattenmann G, Ebert R, Siewert R, Creutzfeldt W.
    Scand J Gastroenterol; 1984 Mar; 19(2):260-6. PubMed ID: 6372074
    [Abstract] [Full Text] [Related]

  • 10. Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels.
    Andersen DK, Elahi D, Brown JC, Tobin JD, Andres R.
    J Clin Invest; 1978 Jul; 62(1):152-61. PubMed ID: 659629
    [Abstract] [Full Text] [Related]

  • 11. Impaired feedback control of fat induced gastric inhibitory polypeptide (GIP) secretion by insulin in obesity and glucose intolerance.
    Ebert R, Frerichs H, Creutzfeldt W.
    Eur J Clin Invest; 1979 Apr; 9(2 Pt 1):129-35. PubMed ID: 111943
    [Abstract] [Full Text] [Related]

  • 12. Radioimmunoassay of gastric inhibitory polypeptide (GIP) and the effect of intraduodenal acidification on glucose-stimulated and unstimulated GIP release in humans.
    Flaten O.
    Scand J Gastroenterol; 1981 Apr; 16(4):545-54. PubMed ID: 7034154
    [Abstract] [Full Text] [Related]

  • 13. Plasma immunoreactive gastric inhibitory polypeptide in obese hyperglycaemic (ob/ob) mice.
    Flatt PR, Bailey CJ, Kwasowski P, Page T, Marks V.
    J Endocrinol; 1984 Jun; 101(3):249-56. PubMed ID: 6374002
    [Abstract] [Full Text] [Related]

  • 14. [The effect of calcium on the release of gastric inhibitory polypeptide (GIP) - with reference to the release of GIP in patients with hyperparathyroidism (author's transl)].
    Nakanome C, Akai H, Umezu M, Toyota T, Goto Y, Furukawa Y, Sato T, Yumita S, Bloom SR.
    Nihon Naibunpi Gakkai Zasshi; 1982 Feb 20; 58(2):98-109. PubMed ID: 7044844
    [Abstract] [Full Text] [Related]

  • 15. The effect of somatostatin on fasting and postprandial plasma GIP, serum insulin, and blood glucose in man.
    Jorde R, Waldum HL, Burhol PG, Lygren I, Schulz TB, Florholmen J, Jenssen TG.
    Scand J Gastroenterol; 1981 Feb 20; 16(1):113-9. PubMed ID: 6112787
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.